1. Home
  2. RVLV vs AMPH Comparison

RVLV vs AMPH Comparison

Compare RVLV & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • AMPH
  • Stock Information
  • Founded
  • RVLV 2003
  • AMPH 1996
  • Country
  • RVLV United States
  • AMPH United States
  • Employees
  • RVLV N/A
  • AMPH N/A
  • Industry
  • RVLV Catalog/Specialty Distribution
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVLV Consumer Discretionary
  • AMPH Health Care
  • Exchange
  • RVLV Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • RVLV 1.4B
  • AMPH 1.1B
  • IPO Year
  • RVLV 2019
  • AMPH 2014
  • Fundamental
  • Price
  • RVLV $23.81
  • AMPH $27.27
  • Analyst Decision
  • RVLV Buy
  • AMPH Buy
  • Analyst Count
  • RVLV 14
  • AMPH 6
  • Target Price
  • RVLV $26.79
  • AMPH $35.50
  • AVG Volume (30 Days)
  • RVLV 1.0M
  • AMPH 395.2K
  • Earning Date
  • RVLV 11-04-2025
  • AMPH 11-05-2025
  • Dividend Yield
  • RVLV N/A
  • AMPH N/A
  • EPS Growth
  • RVLV 38.54
  • AMPH N/A
  • EPS
  • RVLV 0.63
  • AMPH 2.68
  • Revenue
  • RVLV $1,182,554,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • RVLV $9.12
  • AMPH $1.06
  • Revenue Next Year
  • RVLV $6.65
  • AMPH $7.06
  • P/E Ratio
  • RVLV $37.80
  • AMPH $10.25
  • Revenue Growth
  • RVLV 10.68
  • AMPH 1.37
  • 52 Week Low
  • RVLV $16.80
  • AMPH $20.39
  • 52 Week High
  • RVLV $39.58
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 58.90
  • AMPH 43.53
  • Support Level
  • RVLV $22.31
  • AMPH $28.34
  • Resistance Level
  • RVLV $24.29
  • AMPH $29.43
  • Average True Range (ATR)
  • RVLV 0.89
  • AMPH 0.86
  • MACD
  • RVLV 0.05
  • AMPH -0.54
  • Stochastic Oscillator
  • RVLV 84.18
  • AMPH 0.99

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: